Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade

Treatment with immune checkpoint inhibitors has altered the course of malignant melanoma, with approximately half of the patients with advanced disease surviving for more than 5 years after diagnosis. Currently, there are no biomarker methods for predicting outcome from immunotherapy. Here, we obtai...

Descripción completa

Detalles Bibliográficos
Autores principales: Vathiotis, Ioannis A., Salichos, Leonidas, Martinez-Morilla, Sandra, Gavrielatou, Niki, Aung, Thazin Nwe, Shafi, Saba, Wong, Pok Fai, Jessel, Shlomit, Kluger, Harriet M., Syrigos, Konstantinos N., Warren, Sarah, Gerstein, Mark, Rimm, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755314/
https://www.ncbi.nlm.nih.gov/pubmed/36522538
http://dx.doi.org/10.1038/s41698-022-00330-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755314/
https://www.ncbi.nlm.nih.gov/pubmed/36522538
http://dx.doi.org/10.1038/s41698-022-00330-3

Ejemplares similares